Cargando…

Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities

Treatment for opioid use disorder in the United States evolved in response to changing federal policy and advances in science. Inpatient care began in 1935 with the US Public Health Hospitals in Lexington, Kentucky, and Fort Worth, Texas. Outpatient clinics emerged in the 1960s to provide aftercare....

Descripción completa

Detalles Bibliográficos
Autores principales:	McCarty, Dennis, Priest, Kelsey C., Korthuis, P. Todd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880741/ https://www.ncbi.nlm.nih.gov/pubmed/29272165 http://dx.doi.org/10.1146/annurev-publhealth-040617-013526

Ejemplares similares

Opioid use disorder and treatment: challenges and opportunities
por: Hoffman, Kim A., et al.
Publicado: (2019)

Expanding Access to Medications for Opioid Use Disorder: Program and Policy Approaches from Outside the Veterans Health Administration
por: Priest, Kelsey C., et al.
Publicado: (2020)

Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication
por: McIlveen, John W., et al.
Publicado: (2021)

Barriers and facilitators to recruitment and enrollment of HIV-infected individuals with opioid use disorder in a clinical trial
por: Hoffman, Kim A., et al.
Publicado: (2019)

Perspectives on extended-release naltrexone induction among patients living with HIV and opioid use disorder: a qualitative analysis
por: Hoffman, Kim A., et al.
Publicado: (2021)

Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study
por: Hartung, Daniel M., et al.
Publicado: (2022)

Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis
por: Levander, Ximena A., et al.
Publicado: (2021)

Making the business case for an addiction medicine consult service: a qualitative analysis
por: Priest, Kelsey C., et al.
Publicado: (2019)

Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis
por: Hoffman, Kim A., et al.
Publicado: (2022)

Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis
por: McCarty, Dennis, et al.
Publicado: (2019)

State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees
por: Lindner, Stephan R., et al.
Publicado: (2023)

Recruitment challenges for a prospective telehealth cohort study
por: Pertl, Kellie, et al.
Publicado: (2022)

Strategies to implement and sustain medication use for alcohol and opioid disorders
por: Ford, James H, et al.
Publicado: (2015)

1007. Criminal Justice Involvement Negatively Impacts Engagement in Treatments for HIV and Opioid Use Disorder in Vietnam
por: King, Caroline, et al.
Publicado: (2020)

Use of single IRBs for multi-site studies: A case report and commentary from a National Drug Abuse Treatment Clinical Trials Network study
por: Nichols, Ceilidh, et al.
Publicado: (2019)

Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio
por: Molfenter, Todd, et al.
Publicado: (2018)

Patient evaluation of a smartphone application for telehealth care of opioid use disorder
por: Bosse, Jordon D., et al.
Publicado: (2022)

Stakeholders in Recovery: Demands, Expectations, and Research Opportunities
por: McCarty, Dennis, et al.
Publicado: (2005)

Sexual Abuse and Future Mental Health Hospitalization in a Swedish National Sample of Men Who Use Opioids
por: Blom Nilsson, Marcus, et al.
Publicado: (2020)

HIV clinic‐based extended‐release naltrexone versus treatment as usual for people with HIV and opioid use disorder: a non‐blinded, randomized non‐inferiority trial
por: Korthuis, P. Todd, et al.
Publicado: (2022)

HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study
por: King, Caroline, et al.
Publicado: (2020)

Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure
por: McCarty, Mark F.
Publicado: (2021)

“Prevention of opioid use disorder: the HOME (housing, opportunities, motivation and engagement) feasibility study”
por: Kelleher, Kelly J., et al.
Publicado: (2021)

Expanding access to medications for opioid use disorder through locally-initiated implementation
por: Wyse, Jessica J., et al.
Publicado: (2022)

Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions
por: Jemberie, Wossenseged Birhane, et al.
Publicado: (2020)

Prevention of mental disorders: evidence, challenges and opportunities
por: Jacka, Felice N, et al.
Publicado: (2014)

End-of-Life Care and Opioid Use in India: Challenges and Opportunities
por: Jacob, Aasems, et al.
Publicado: (2017)

The Changing Opioid Crisis: development, challenges and opportunities
por: Volkow, Nora D., et al.
Publicado: (2020)

Hospital care for opioid use disorder in pregnancy: Challenges and opportunities identified from a Minnesota survey
por: Dopp, Alana, et al.
Publicado: (2020)

Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities
por: Wyse, Jessica J., et al.
Publicado: (2023)

Preventing Opioid Use Disorders among Fishing Industry Workers
por: Walter, Angela Wangari, et al.
Publicado: (2018)

Retention Strategies for Medications for Opioid Use Disorder in Adults: A Rapid Evidence Review
por: Chan, Brian, et al.
Publicado: (2021)

Use of methamphetamine and alcohol among people with opioid use disorder and HIV in Vietnam: a qualitative study
por: Edsall, Andrew, et al.
Publicado: (2021)

Tobacco use disorder and treatment: new challenges and opportunities
por: Ziedonis, Douglas, et al.
Publicado: (2017)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Effects of Naltrexone on Large-Scale Network Interactions in Methamphetamine Use Disorder
por: Kohno, Milky, et al.
Publicado: (2019)

Charting a Path Between Research and Practice in Alcoholism Treatment
por: McCarty, Dennis, et al.
Publicado: (2006)

Challenges and new opportunities for detecting endogenous opioid peptides in reward
por: Conway, Sineadh M., et al.
Publicado: (2022)

Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
por: Meqbil, Yazan J., et al.
Publicado: (2022)

Altered monocyte phenotype and dysregulated innate cytokine responses among people living with HIV and opioid-use disorder
por: Underwood, Michelle L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_57qhehfevdd305viq7pk9s3ege